Discontinued — last reported Q4 '25
Eli Lilly EPS (Basic) increased by 19.1% to $7.41 in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 51.2%, from $4.90 to $7.41. Over 4 years (FY 2021 to FY 2025), EPS (Basic) shows an upward trend with a 39.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher values indicate more value is being generated for each individual share held.
The portion of a company's profit allocated to each outstanding share of common stock, calculated using the actual numbe...
This is a standard benchmark used to compare the earnings power of companies regardless of their total size or market capitalization.
is_eps_basic| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.53 | $1.22 | $1.91 | $2.11 | $1.06 | $1.61 | $2.15 | $1.49 | $1.96 | -$0.06 | $2.43 | $2.49 | $3.29 | $1.08 | $4.90 | $3.07 | $6.30 | $6.22 | $7.41 |
| QoQ Change | — | -20.3% | +56.6% | +10.5% | -49.8% | +51.9% | +33.5% | -30.7% | +31.5% | -103.1% | >999% | +2.5% | +32.1% | -67.2% | +353.7% | -37.3% | +105.2% | -1.3% | +19.1% |
| YoY Change | — | — | — | — | -30.7% | +32.0% | +12.6% | -29.4% | +84.9% | -103.7% | +13.0% | +67.1% | +67.9% | >999% | +101.6% | +23.3% | +91.5% | +475.9% | +51.2% |
We use cookies for analytics. See our Privacy and Cookie Policy.